A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Naltrexone (Primary) ; Buprenorphine
- Indications Opioid abuse
- Focus Therapeutic Use
- Sponsors Alkermes plc
- 24 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Dec 2016 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 21 Dec 2016 Planned primary completion date changed from 1 May 2017 to 1 Nov 2017.